Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ARQL > SEC Filings for ARQL > Form 8-K on 30-Sep-2013All Recent SEC Filings

Show all filings for ARQULE INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for ARQULE INC


30-Sep-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On September 30, 2013, ArQule, Inc. (the "Registrant") reported that data presented at the European Cancer Congress demonstrated clinical benefits of treatment with the combination of tivantinib and erlotinib in patients with non-squamous, non-small cell lung cancer whose tumors expressed high levels of met protein.

The Registrant's press release dated September 30, 2013, a copy of which is attached hereto as Exhibit 99.1, is incorporated herein by reference.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit 99.1 Text of press release dated September 30, 2013 reporting data demonstrating clinical benefits.

  Add ARQL to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ARQL - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.